You are here: Welcome » COVID-19 Vaccines » Adverse Events Following COVID-19 Vaccination » COVID-19 Vaccine Associated Vasculitis

COVID-19 Vaccine Associated Vasculitis

Peer-Reviewed Scientific papers regarding COVID-19 Vaccine Associated Vasculitis, including Microscopic Polyangiitis

ANCA-associated vasculitis after Pfizer-BioNTech COVID-19 vaccine

propylthiouracil-induced neutrophil anti-cytoplasmic antibody-associated vasculitis after COVID-19 vaccination

IgA vasculitis in adult patient after vaccination with ChadOx1 nCoV-19

A case of leukocytoclastic vasculitis after vaccination with a SARS-CoV2 vaccine: case report

A case of ANCA-associated vasculitis after AZD1222 (Oxford-AstraZeneca) SARS-CoV-2 vaccination: victim or causality?.

Leukocytoclastic vasculitis as a cutaneous manifestation of ChAdOx1 corona virus vaccine nCoV-19 (recombinant)

Induction of cutaneous leukocytoclastic vasculitis after ChAdOx1 nCoV-19 vaccine.

Recurrent ANCA-associated vasculitis after Oxford AstraZeneca ChAdOx1-S COVID-19 vaccination: a case series of two patients

Cutaneous lymphocytic vasculitis after administration of the second dose of AZD1222 (Oxford-AstraZeneca) Severe acute respiratory syndrome Coronavirus 2 vaccine: chance or causality.

Case report: anti-neutrophil cytoplasmic antibody-associated vasculitis with acute renal failure and pulmonary hemorrhage can occur after COVID-19 vaccination

Intracerebral hemorrhage due to vasculitis following COVID-19 vaccination: case report

COVID-19 vaccine-induced urticarial vasculitis.

ANCA-associated vasculitis after Pfizer-BioNTech COVID-19 vaccine.

New-onset leukocytoclastic vasculitis after COVID-19 vaccine

Cutaneous small vessel vasculitis after COVID-19 vaccine.

Outbreak of leukocytoclastic vasculitis after COVID-19 vaccine

Leukocytoclastic vasculitis after exposure to COVID-19 vaccine

Vasculitis and bursitis in [ 18 F] FDG-PET/CT after COVID-19 mRNA vaccine: post hoc ergo propter hoc?

Cutaneous lymphocytic vasculitis after administration of COVID-19 mRNA vaccine

Cutaneous leukocytoclastic vasculitis induced by Sinovac COVID-19 vaccine.

Reactivation of IgA vasculitis after vaccination with COVID-19

Varicella-zoster virus-related small-vessel vasculitis after Pfizer-BioNTech COVID-19 vaccination.

Imaging in vascular medicine: leukocytoclastic vasculitis after COVID-19 vaccine booster

Cutaneous vasculitis following COVID-19 vaccination.

Possible case of COVID-19 mRNA vaccine-induced small-vessel vasculitis.

IgA vasculitis following COVID-19 vaccination in an adult

Propylthiouracil-induced anti-neutrophil cytoplasmic antibody-associated vasculitis following vaccination with COVID-19

Coronavirus disease vaccine 2019 (COVID-19) in systemic lupus erythematosus and neutrophil anti-cytoplasmic antibody-associated vasculitis

Reactivation of IgA vasculitis after COVID-19 vaccination

First description of immune complex vasculitis after COVID-19 vaccination with BNT162b2: case report.

Nephrotic syndrome and vasculitis after SARS-CoV-2 vaccine: true association or circumstantial.

Occurrence of de novo cutaneous vasculitis after vaccination against coronavirus disease (COVID-19).

Asymmetric cutaneous vasculitis after COVID-19 vaccination with unusual preponderance of eosinophils.

Granulomatous vasculitis after AstraZeneca anti-SARS-CoV-2 vaccine.

A case of generalized Sweet’s syndrome with vasculitis triggered by recent vaccination with COVID-19

Small-vessel vasculitis following Oxford-AstraZeneca vaccination against SARS-CoV-2

Cutaneous vasculitis after severe acute respiratory syndrome coronavirus 2 vaccine.

Leukocytoclastic vasculitis after coronavirus disease vaccination 2019

Outbreaks of mixed cryoglobulinemia vasculitis after vaccination against SARS-CoV-2

Cutaneous small-vessel vasculitis after vaccination with a single dose of Janssen Ad26.COV2.S

Case of immunoglobulin A vasculitis after vaccination against coronavirus disease 2019

Relapse of microscopic polyangiitis after COVID-19 vaccination: case report.